Concepedia

Rishika Prasad

RP

9

Publications

567

Citations

9

H-Index

2019

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Baylor College of Medicine

University of Michigan

The University of Texas Health Science Center at Houston

Yale University

Rishika Prasad is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, t cell immunity, and tumor immunity.

ORCID

Top concepts

Publications per year

2019–2024

9

Publications

9

ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer

Cheng‐En Hsieh, Sunil Krishnan, Ren‐Chin Wu et al. · Science Immunology · 2022 · 140 citations · Full text

, , +17

Mucus-degrading Bacteroides link carbapenems to aggravated graft-versus-host disease

Eiko Hayase, Tomo Hayase, Mohamed A. Jamal et al. · Cell · 2022 · 101 citations · Full text

, , +6

A Novel Mitochondrial Inhibitor Blocks MAPK Pathway and Overcomes MAPK Inhibitor Resistance in Melanoma

Y.N. Vashisht Gopal, Seth T. Gammon, Rishika Prasad et al. · Clinical Cancer Research · 2019 · 92 citations · Full text

High potency STING agonists engage unique myeloid pathways to reverse pancreatic cancer immune privilege

Casey R. Ager, Akash R. Boda, Kimal Rajapakshe et al. · Journal for ImmunoTherapy of Cancer · 2021 · 65 citations · Full text

Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment

Zaker Schwabkey, Diana H. Wiesnoski, Chia‐Chi Chang et al. · Science Translational Medicine · 2022 · 53 citations · Full text

Rows per page

1–5 of 9